Pub Date : 2022-06-28DOI: 10.1097/01.REO.0000000000000310
D. Doubblestein, Bryan A. Spinelli, A. Goldberg, C. A. Larson, A. Yorke
Background: Survivors of breast cancer (SBC) with breast cancer–related lymphedema (BCRL) have demonstrated neuromusculoskeletal restrictions, sensorimotor impairments, postural instability, and balance deficits. To date, there have been no studies that investigate outcome measures (OMs) used by certified lymphedema therapists (CLTs) with SBC with BCRL. Objective: The purposes of this study were to (1) determine types of OMs used and their frequency of use by CLTs with SBC with BCRL and their differences between therapy professions, and (2) identify unique characteristic predictors for use of OMs. Methods: Cross-sectional online survey research design. Electronic surveys were distributed to CLTs from various institutions. Data from 70 physical therapists (PTs) and 41 occupational therapists were analyzed from 130 completed surveys. Results: Sixteen OMs used most often assessed joint function, flexibility, strength, pain, volume, sensation, tissue consistency, body composition, health-related quality of life, and upper quadrant function. There were differences between PTs and occupational therapists in use of OMs. Lymphology Association of North America certification, practice setting, and profession (physical therapy and occupational therapy) predicted the use of some OMs. Conclusions: This study identified individual OMs used on SBC with BCRL in clinical practice among interdisciplinary CLTs. The number of OMs used to assess body functions and structures exceed those OMs for activities and participation, which may be influenced by CLT profession, Lymphology Association of North America certification, and level of highest degree.
{"title":"Use of Outcome Measures by Certified Lymphedema Therapists With Survivors of Breast Cancer With Breast Cancer–Related Lymphedema","authors":"D. Doubblestein, Bryan A. Spinelli, A. Goldberg, C. A. Larson, A. Yorke","doi":"10.1097/01.REO.0000000000000310","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000310","url":null,"abstract":"Background: Survivors of breast cancer (SBC) with breast cancer–related lymphedema (BCRL) have demonstrated neuromusculoskeletal restrictions, sensorimotor impairments, postural instability, and balance deficits. To date, there have been no studies that investigate outcome measures (OMs) used by certified lymphedema therapists (CLTs) with SBC with BCRL. Objective: The purposes of this study were to (1) determine types of OMs used and their frequency of use by CLTs with SBC with BCRL and their differences between therapy professions, and (2) identify unique characteristic predictors for use of OMs. Methods: Cross-sectional online survey research design. Electronic surveys were distributed to CLTs from various institutions. Data from 70 physical therapists (PTs) and 41 occupational therapists were analyzed from 130 completed surveys. Results: Sixteen OMs used most often assessed joint function, flexibility, strength, pain, volume, sensation, tissue consistency, body composition, health-related quality of life, and upper quadrant function. There were differences between PTs and occupational therapists in use of OMs. Lymphology Association of North America certification, practice setting, and profession (physical therapy and occupational therapy) predicted the use of some OMs. Conclusions: This study identified individual OMs used on SBC with BCRL in clinical practice among interdisciplinary CLTs. The number of OMs used to assess body functions and structures exceed those OMs for activities and participation, which may be influenced by CLT profession, Lymphology Association of North America certification, and level of highest degree.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"35 1","pages":"34 - 46"},"PeriodicalIF":0.9,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78758691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-28DOI: 10.1097/01.REO.0000000000000313
Abigail Simone, J. Blackwood
Background: Cancer-related cognitive dysfunction (CRCD) refers to changes in cognitive functioning that occurs as a result of cancer treatment including radiation, hormone therapy, surgery, and most often, chemotherapy. While various nonpharmacologic interventions for cognitive impairments have been studied in younger adults with a history of cancer and in older adult populations without cancer, limited information is available regarding nonpharmacologic interventions for older adults with a history of cancer. Purpose: The purpose of this systematic review is to describe the current nonpharmacologic interventions for older adults with CRCD. Data Sources: PubMed, MEDLINE, CINAHL, and Embase. Study Selection: Articles meeting inclusion criteria were appraised by 2 reviewers independently. The Cochrane Risk of Bias Assessment was used to assess study quality. Data Extraction: The search located 3441 articles; 4 met inclusion criteria. Data Synthesis: Nonpharmacologic interventions addressed the cognitive processes of executive function (n = 2), attention (n = 1), learning/memory (n = 2), perceptual-motor (n = 1), and global cognitive function (n = 3). Two studies used exercise-based interventions and 2 employed cognitive training interventions to address CRCD. Discussion and Limitations: Although improvements in CRCD were found, the interventions used and measure type suggested a high degree of variability challenging the ability to make recommendations for the use of these nonpharmacologic interventions without completion of further studies. Conclusions: As promising evidence has been reported of the effect of aerobic exercise and cognitive training interventions on CRCD in both young survivors of cancer and older adults without cancer, further study is needed to replicate those benefits in older adults with CRCD.
{"title":"Improving Cognitive Function of Older Adults With a History of Cancer Using Nonpharmacologic Interventions: A Systematic Review","authors":"Abigail Simone, J. Blackwood","doi":"10.1097/01.REO.0000000000000313","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000313","url":null,"abstract":"Background: Cancer-related cognitive dysfunction (CRCD) refers to changes in cognitive functioning that occurs as a result of cancer treatment including radiation, hormone therapy, surgery, and most often, chemotherapy. While various nonpharmacologic interventions for cognitive impairments have been studied in younger adults with a history of cancer and in older adult populations without cancer, limited information is available regarding nonpharmacologic interventions for older adults with a history of cancer. Purpose: The purpose of this systematic review is to describe the current nonpharmacologic interventions for older adults with CRCD. Data Sources: PubMed, MEDLINE, CINAHL, and Embase. Study Selection: Articles meeting inclusion criteria were appraised by 2 reviewers independently. The Cochrane Risk of Bias Assessment was used to assess study quality. Data Extraction: The search located 3441 articles; 4 met inclusion criteria. Data Synthesis: Nonpharmacologic interventions addressed the cognitive processes of executive function (n = 2), attention (n = 1), learning/memory (n = 2), perceptual-motor (n = 1), and global cognitive function (n = 3). Two studies used exercise-based interventions and 2 employed cognitive training interventions to address CRCD. Discussion and Limitations: Although improvements in CRCD were found, the interventions used and measure type suggested a high degree of variability challenging the ability to make recommendations for the use of these nonpharmacologic interventions without completion of further studies. Conclusions: As promising evidence has been reported of the effect of aerobic exercise and cognitive training interventions on CRCD in both young survivors of cancer and older adults without cancer, further study is needed to replicate those benefits in older adults with CRCD.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"91 5 1","pages":"14 - 22"},"PeriodicalIF":0.9,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83660297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-09DOI: 10.1097/01.REO.0000000000000309
Joy Nashed, Akshita Sundaresh, Colin Laurie, Carolyn J. Page, Claire Hines, Su Ming Ong, Susie Black, S. Heywood
Background: Primary malignant bone tumors are a rare form of cancer, treated with limb salvage surgery (LSS), which includes sacrifices of muscle and bone. Purpose: To systematically appraise outcomes of gait, physical function (including dynamic balance, transfers, sit-to-stand, and stair climbing) and muscle performance related to the trunk and lower limb in current literature for individuals who have undergone LSS due to a primary bone tumor. Data Sources: Medline, Cochrane, and PEDro databases were searched from inception to June 2020. Study Selection: Following PRISMA guidelines, articles were screened by 2 reviewers independently (J.N. and C.H.) to determine eligibility based on population of interest (adults who have had LSS) and outcomes (gait, trunk, and lower limb physical function or muscle performance). Discrepancies were resolved with a third reviewer until a mutual consensus was reached (S.H.). Data Extraction: Data on gait, function, and muscle strength were extracted and grouped based on the surgical location (ankle, proximal tibia, distal femur, proximal femur/hip, or pelvic region). Data Synthesis: Data were extracted into tables and grouped first based on participants' surgical site and then based on a domain of outcomes (individual or mean group results for gait measures, strength, balance, use of walking aids, or ability to complete a task such as balance or stairs). Results: One thousand four hundred and forty-five abstracts were screened with 32 studies (354 participants) included in the review. Gait speed was reported in 16 studies and use of walking aids reported in 14 studies; these were the most reported outcomes in the review. Knee extensor strength was reported in 6 studies. Following internal hemipelvectomy surgery, 42% of participants ambulated without a walking aid and gait speed was reported as 0.61 to 1.6 m/s. For those who underwent surgery at the hip, 71% ambulated independently with an average gait speed of 0.94 to 1.20 m/s. Of participants who underwent surgery at the knee, 89% ambulated independently with an average gait speed of 0.36 to 1.32 m/s. Following knee LSS, knee extensor strength of the operated limb varied from 2% to 84% compared with the nonoperated side. Physical function outcome measures that were reported in the studies included the Timed Up and Go (TUG), single-leg balance and stair climbing. Two studies reported the TUG for participants who underwent LSS at the knee and 1 study for participants who underwent LSS at mixed locations on the lower limb. Single-leg balance and stair climbing were both reported in the same study on participants who had undergone LSS at the ankle. Discussion: Approximately 50% of people following hemipelvectomy surgery required a walking aid, with majority of the participants (58%) displaying a gait speed less than 1.1 m/s. Conversely, few people who underwent LSS at the knee and ankle required the use of walking aids. Knee and ankle-related LSS may more likely lea
{"title":"Gait, Function, and Strength Following Lower Limb Salvage Surgery for a Primary Malignant Bone Tumor: A Systematic Review","authors":"Joy Nashed, Akshita Sundaresh, Colin Laurie, Carolyn J. Page, Claire Hines, Su Ming Ong, Susie Black, S. Heywood","doi":"10.1097/01.REO.0000000000000309","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000309","url":null,"abstract":"Background: Primary malignant bone tumors are a rare form of cancer, treated with limb salvage surgery (LSS), which includes sacrifices of muscle and bone. Purpose: To systematically appraise outcomes of gait, physical function (including dynamic balance, transfers, sit-to-stand, and stair climbing) and muscle performance related to the trunk and lower limb in current literature for individuals who have undergone LSS due to a primary bone tumor. Data Sources: Medline, Cochrane, and PEDro databases were searched from inception to June 2020. Study Selection: Following PRISMA guidelines, articles were screened by 2 reviewers independently (J.N. and C.H.) to determine eligibility based on population of interest (adults who have had LSS) and outcomes (gait, trunk, and lower limb physical function or muscle performance). Discrepancies were resolved with a third reviewer until a mutual consensus was reached (S.H.). Data Extraction: Data on gait, function, and muscle strength were extracted and grouped based on the surgical location (ankle, proximal tibia, distal femur, proximal femur/hip, or pelvic region). Data Synthesis: Data were extracted into tables and grouped first based on participants' surgical site and then based on a domain of outcomes (individual or mean group results for gait measures, strength, balance, use of walking aids, or ability to complete a task such as balance or stairs). Results: One thousand four hundred and forty-five abstracts were screened with 32 studies (354 participants) included in the review. Gait speed was reported in 16 studies and use of walking aids reported in 14 studies; these were the most reported outcomes in the review. Knee extensor strength was reported in 6 studies. Following internal hemipelvectomy surgery, 42% of participants ambulated without a walking aid and gait speed was reported as 0.61 to 1.6 m/s. For those who underwent surgery at the hip, 71% ambulated independently with an average gait speed of 0.94 to 1.20 m/s. Of participants who underwent surgery at the knee, 89% ambulated independently with an average gait speed of 0.36 to 1.32 m/s. Following knee LSS, knee extensor strength of the operated limb varied from 2% to 84% compared with the nonoperated side. Physical function outcome measures that were reported in the studies included the Timed Up and Go (TUG), single-leg balance and stair climbing. Two studies reported the TUG for participants who underwent LSS at the knee and 1 study for participants who underwent LSS at mixed locations on the lower limb. Single-leg balance and stair climbing were both reported in the same study on participants who had undergone LSS at the ankle. Discussion: Approximately 50% of people following hemipelvectomy surgery required a walking aid, with majority of the participants (58%) displaying a gait speed less than 1.1 m/s. Conversely, few people who underwent LSS at the knee and ankle required the use of walking aids. Knee and ankle-related LSS may more likely lea","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"47 1","pages":"105 - 115"},"PeriodicalIF":0.9,"publicationDate":"2022-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89802785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-03DOI: 10.1097/01.REO.0000000000000284
Larissa Melo Sampaio, H. Fuzari
Objective: To investigate whether inspiratory muscle training improves respiratory muscle strength and function and reduces dyspnea and fatigue in hematopoietic stem cell recipients. Design: A systematic review and meta-analysis of randomized controlled trials. Participants: People with hematological neoplasms who underwent hematopoietic stem cell transplantation. Intervention: Inspiratory muscle training with POWER breath Plus, POWERbreathe, Classic, and Threshold devices, with a load of 40% of the maximum inspiratory pressure. Outcome Measures: The primary outcomes were maximal inspiratory pressure, maximal expiratory pressure, forced expiratory volume in the first second of expiration (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio. Secondary outcomes were dyspnea, fatigue, respiratory rate, peripheral O2 saturation, quality of life, and functional capacity. Results: The search identified 3 eligible studies with a sample of 108 participants. Maximal inspiratory pressure was higher in the intervention group in the 3 studies reviewed, with an average difference of −9.3 cm H2O, −31.94 cm H2O, and −16 cm H2O in relation to the control group after inspiratory muscle training. One study found an improvement in the distance covered in the 6-minute walk test (34.22 m) and in the distance covered in the modified incremental shuttle walking test (66.43 m) in the intervention group. Limitation: This systematic review includes only 3 randomized controlled clinical trials. Conclusion: Inspiratory muscle training is effective in increasing inspiratory muscle strength and functional capacity in bone marrow transplant recipients. However, its effects on fatigue and dyspnea remain uncertain.
目的:探讨吸气肌训练是否能改善造血干细胞受者的呼吸肌力量和功能，减轻呼吸困难和疲劳。设计:随机对照试验的系统回顾和荟萃分析。参与者:接受造血干细胞移植的血液肿瘤患者。干预:使用POWERbreath Plus、POWERbreathe、Classic和Threshold设备进行吸气肌训练，负荷为最大吸气压力的40%。结果指标:主要结果为最大吸气压力、最大呼气压力、呼气第一秒用力呼气量(FEV1)、用力肺活量(FVC)和FEV1/FVC比值。次要结局为呼吸困难、疲劳、呼吸频率、外周氧饱和度、生活质量和功能能力。结果:搜索确定了3个符合条件的研究，样本为108名参与者。在回顾的3项研究中，干预组的最大吸气压力较高，与对照组相比，吸气肌训练后的最大吸气压力平均差值分别为- 9.3 cm H2O、- 31.94 cm H2O和- 16 cm H2O。一项研究发现，干预组在6分钟步行测试中行走距离(34.22米)和改进的增量穿梭行走测试中行走距离(66.43米)有所改善。局限性:本系统综述仅包括3个随机对照临床试验。结论:吸气肌训练能有效提高骨髓移植受者的吸气肌力量和功能。然而，其对疲劳和呼吸困难的影响仍不确定。
{"title":"Efficacy of Inspiratory Muscle Training on Respiratory Muscle Strength in Hematopoietic Stem Cell Recipients: A Systematic Review and Meta-analysis","authors":"Larissa Melo Sampaio, H. Fuzari","doi":"10.1097/01.REO.0000000000000284","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000284","url":null,"abstract":"Objective: To investigate whether inspiratory muscle training improves respiratory muscle strength and function and reduces dyspnea and fatigue in hematopoietic stem cell recipients. Design: A systematic review and meta-analysis of randomized controlled trials. Participants: People with hematological neoplasms who underwent hematopoietic stem cell transplantation. Intervention: Inspiratory muscle training with POWER breath Plus, POWERbreathe, Classic, and Threshold devices, with a load of 40% of the maximum inspiratory pressure. Outcome Measures: The primary outcomes were maximal inspiratory pressure, maximal expiratory pressure, forced expiratory volume in the first second of expiration (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio. Secondary outcomes were dyspnea, fatigue, respiratory rate, peripheral O2 saturation, quality of life, and functional capacity. Results: The search identified 3 eligible studies with a sample of 108 participants. Maximal inspiratory pressure was higher in the intervention group in the 3 studies reviewed, with an average difference of −9.3 cm H2O, −31.94 cm H2O, and −16 cm H2O in relation to the control group after inspiratory muscle training. One study found an improvement in the distance covered in the 6-minute walk test (34.22 m) and in the distance covered in the modified incremental shuttle walking test (66.43 m) in the intervention group. Limitation: This systematic review includes only 3 randomized controlled clinical trials. Conclusion: Inspiratory muscle training is effective in increasing inspiratory muscle strength and functional capacity in bone marrow transplant recipients. However, its effects on fatigue and dyspnea remain uncertain.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"9 1","pages":"96 - 104"},"PeriodicalIF":0.9,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87736797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1097/01.reo.0000000000000311
E. Lowe
{"title":"Shoulder Dysfunction After Lung Cancer Resection","authors":"E. Lowe","doi":"10.1097/01.reo.0000000000000311","DOIUrl":"https://doi.org/10.1097/01.reo.0000000000000311","url":null,"abstract":"","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"25 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84430417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1097/01.reo.0000000000000315
M. Fisher
{"title":"Trustworthiness and Quality in Research for Clinical Application","authors":"M. Fisher","doi":"10.1097/01.reo.0000000000000315","DOIUrl":"https://doi.org/10.1097/01.reo.0000000000000315","url":null,"abstract":"","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"85 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83913166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-28DOI: 10.1097/01.REO.0000000000000305
Lisa J. Wood Magee, Janet A. Kneiss, S. Wechsler, Ayesha Singh, A. Fox, J. Peppercorn, W. Pirl
Purpose: To examine whether survivors of breast cancer (SBC) with persistent cancer-related fatigue (CRF) have greater fatigability than their nonfatigued counterparts. Methods: Measures of fatigability, including endurance, perceived exertion, lower extremity muscle force and power, and sit-to-stand time (STST), were assessed in 43 women (21 with persistent CRF) after a sit-to-stand fatigue (STSF) task. Group differences in fatigability outcomes were examined using analysis of variance. Results: SBC with persistent CRF had lower endurance (P = .003, ηp2 = 0.205) and reported greater perceived exertion (P < .001, ηp2 = 0.284) during the STSF task, and demonstrated lower postexertional force (P = .035, ηp2 = 0.109), power (P = .001, ηp2 = 0.242), and slower STST (P = .001, ηp2 = 0.258) compared with SBC without CRF. Conclusions: SBC with persistent CRF have increased fatigability compared with those without CRF. Our findings suggest that exercise recommendations for women with persistent CRF after breast cancer treatment should include activities that increase lower limb muscle force and power, such as heavy resistance or explosive-type strength training.
{"title":"Increased Fatigability in Women With Persistent Cancer-Related Fatigue After Breast Cancer Treatment: A Pilot Study","authors":"Lisa J. Wood Magee, Janet A. Kneiss, S. Wechsler, Ayesha Singh, A. Fox, J. Peppercorn, W. Pirl","doi":"10.1097/01.REO.0000000000000305","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000305","url":null,"abstract":"Purpose: To examine whether survivors of breast cancer (SBC) with persistent cancer-related fatigue (CRF) have greater fatigability than their nonfatigued counterparts. Methods: Measures of fatigability, including endurance, perceived exertion, lower extremity muscle force and power, and sit-to-stand time (STST), were assessed in 43 women (21 with persistent CRF) after a sit-to-stand fatigue (STSF) task. Group differences in fatigability outcomes were examined using analysis of variance. Results: SBC with persistent CRF had lower endurance (P = .003, ηp2 = 0.205) and reported greater perceived exertion (P < .001, ηp2 = 0.284) during the STSF task, and demonstrated lower postexertional force (P = .035, ηp2 = 0.109), power (P = .001, ηp2 = 0.242), and slower STST (P = .001, ηp2 = 0.258) compared with SBC without CRF. Conclusions: SBC with persistent CRF have increased fatigability compared with those without CRF. Our findings suggest that exercise recommendations for women with persistent CRF after breast cancer treatment should include activities that increase lower limb muscle force and power, such as heavy resistance or explosive-type strength training.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"33 1","pages":"135 - 144"},"PeriodicalIF":0.9,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86528807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-06DOI: 10.1097/01.REO.0000000000000301
Jill E. Mayer, Kayleigh Plumeau
Background and Purpose: Home exercise programs (HEPs) improve quality of life (QoL), physical function, and fatigue in individuals recovering from cancer; however, they often lack supervision and individualization. Use of a weekly telephone call by a physical therapist (PT) may provide substantial guidance to improve outcomes and adherence. The purpose of this study was to determine the effect of weekly calls in addition to an individualized HEP on physical function, QoL, fatigue, and adherence in people with cancer. Methods: A prospective 2-armed single-cohort design implemented with survivors of cancer in early recovery. Control and intervention groups received in-home instruction of a PT-prescribed, 8-week HEP. The intervention group received weekly phone calls while the control group had no formal follow-up or program monitoring. Outcome measures assessed pre-/postintervention: 6-minute walk test (6MWT), Fullerton Advanced Balance Scale, European Organization of Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30), and Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT). Nonparametric statistics were used to analyze changes within and between groups. Results: Fifteen participants (n = 7 intervention and n = 8 control) completed the study. The intervention group improved significantly in all outcomes except the 6MWT (P < .05). The control group did not demonstrate any significant improvements. Between groups, there was a significant difference at program completion in the FACIT (P = .007) and EORTC QLQ-C30 physical function subscale (P = .042). Limitations: A small, heterogeneous sample. Conclusions: An individualized HEP with weekly calls may be a safe and effective way to improve outcomes of physical function, QoL, and fatigue in individuals with cancer during early recovery.
{"title":"Weekly Telephone Call Impacts Outcomes of an Individualized Home Exercise Program in People Recovering From Cancer","authors":"Jill E. Mayer, Kayleigh Plumeau","doi":"10.1097/01.REO.0000000000000301","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000301","url":null,"abstract":"Background and Purpose: Home exercise programs (HEPs) improve quality of life (QoL), physical function, and fatigue in individuals recovering from cancer; however, they often lack supervision and individualization. Use of a weekly telephone call by a physical therapist (PT) may provide substantial guidance to improve outcomes and adherence. The purpose of this study was to determine the effect of weekly calls in addition to an individualized HEP on physical function, QoL, fatigue, and adherence in people with cancer. Methods: A prospective 2-armed single-cohort design implemented with survivors of cancer in early recovery. Control and intervention groups received in-home instruction of a PT-prescribed, 8-week HEP. The intervention group received weekly phone calls while the control group had no formal follow-up or program monitoring. Outcome measures assessed pre-/postintervention: 6-minute walk test (6MWT), Fullerton Advanced Balance Scale, European Organization of Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30), and Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT). Nonparametric statistics were used to analyze changes within and between groups. Results: Fifteen participants (n = 7 intervention and n = 8 control) completed the study. The intervention group improved significantly in all outcomes except the 6MWT (P < .05). The control group did not demonstrate any significant improvements. Between groups, there was a significant difference at program completion in the FACIT (P = .007) and EORTC QLQ-C30 physical function subscale (P = .042). Limitations: A small, heterogeneous sample. Conclusions: An individualized HEP with weekly calls may be a safe and effective way to improve outcomes of physical function, QoL, and fatigue in individuals with cancer during early recovery.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"6 1","pages":"89 - 97"},"PeriodicalIF":0.9,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87654491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-06DOI: 10.1097/01.REO.0000000000000303
Ehsan Sinaei, M. Ansari, Z. Zakeri, Forouzan Mousavi, Maryam Siyanat, Amin Kordi Yoosefinejad
Background and Objective: Reduced balance performance is among the most common consequences of chemotherapy-induced peripheral neuropathy in women with breast cancer who receive taxane-based chemotherapy (TBC). We aimed to assess the responsiveness and interrater reliability of the short form of the Fullerton Advanced Balance (SF-FAB) scale in monitoring the balance status of women with breast cancer following a cycle of TBC and the scale's potential to detect balance changes in these people. Methods: In this measurement-focused study, 33 women diagnosed with breast cancer were recruited. After baseline assessments of the SF-FAB and the Revised and Shortened Total Neuropathy Score (TNSr-SF) by 2 raters, participants received 6 to 10 sessions of TBC with a mean interval of 2.61 weeks. After cessation of the chemotherapy cycle, outcomes were reassessed. Twenty-eight participants with a mean age of 46.50 (10.46) years completed the trial. Results: After the interventions, the SF-FAB score decreased significantly (P = .02) and the neuropathy score increased significantly (P < .001), indicating lowered balance and aggravated neuropathy. This study showed excellent interrater reliability for the total score of the SF-FAB, before and after TBC (intraclass correlation coefficient(2,2) ≥ 0.90, 95% confidence interval = 0.96-0.99). The internal consistency of the scale was acceptable (Cronbach's α = 0.97) and a moderate negative correlation was observed between the SF-FAB and neuropathy scores (r = −0.63), which was statistically significant (P ˂ .001). Conclusion: Reliable functional tests that are feasible and easy to apply, such as the SF-FAB scale, contribute to a quick screen of women with cancer who undergo TBC as a preliminary to further comprehensive assessments if necessary.
{"title":"Responsiveness and Interrater Reliability of the Short Form of Fullerton Advance Balance Scale in Women With Breast Cancer Following Chemotherapy","authors":"Ehsan Sinaei, M. Ansari, Z. Zakeri, Forouzan Mousavi, Maryam Siyanat, Amin Kordi Yoosefinejad","doi":"10.1097/01.REO.0000000000000303","DOIUrl":"https://doi.org/10.1097/01.REO.0000000000000303","url":null,"abstract":"Background and Objective: Reduced balance performance is among the most common consequences of chemotherapy-induced peripheral neuropathy in women with breast cancer who receive taxane-based chemotherapy (TBC). We aimed to assess the responsiveness and interrater reliability of the short form of the Fullerton Advanced Balance (SF-FAB) scale in monitoring the balance status of women with breast cancer following a cycle of TBC and the scale's potential to detect balance changes in these people. Methods: In this measurement-focused study, 33 women diagnosed with breast cancer were recruited. After baseline assessments of the SF-FAB and the Revised and Shortened Total Neuropathy Score (TNSr-SF) by 2 raters, participants received 6 to 10 sessions of TBC with a mean interval of 2.61 weeks. After cessation of the chemotherapy cycle, outcomes were reassessed. Twenty-eight participants with a mean age of 46.50 (10.46) years completed the trial. Results: After the interventions, the SF-FAB score decreased significantly (P = .02) and the neuropathy score increased significantly (P < .001), indicating lowered balance and aggravated neuropathy. This study showed excellent interrater reliability for the total score of the SF-FAB, before and after TBC (intraclass correlation coefficient(2,2) ≥ 0.90, 95% confidence interval = 0.96-0.99). The internal consistency of the scale was acceptable (Cronbach's α = 0.97) and a moderate negative correlation was observed between the SF-FAB and neuropathy scores (r = −0.63), which was statistically significant (P ˂ .001). Conclusion: Reliable functional tests that are feasible and easy to apply, such as the SF-FAB scale, contribute to a quick screen of women with cancer who undergo TBC as a preliminary to further comprehensive assessments if necessary.","PeriodicalId":54153,"journal":{"name":"Rehabilitation Oncology","volume":"43 1","pages":"E54 - E60"},"PeriodicalIF":0.9,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85775497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：